MiniMed Group, Inc.
▲ 2 upgrades / ▼ 0 downgrades / 1 reiterations from 3 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | Jefferies | initiate | — → Hold | — | 52% |
| Oct 8, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Oct 7, 2026 | Barclays | initiate | — → Equal-Weight | — | 53% |
| Sep 24, 2026 | Truist Securities | initiate | — → Buy | — | 54% |
| Sep 3, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Sep 2, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Sep 2, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Sep 2, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Sep 2, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Sep 2, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Sep 2, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Sep 1, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jun 4, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| May 18, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| May 12, 2026 | Benchmark | initiate | — → Buy | — | 54% |
| Apr 1, 2026 | Barclays | initiate | — → Overweight | — | 53% |
| Mar 31, 2026 | William Blair | initiate | — → Outperform | — | 48% |
| Mar 31, 2026 | Citigroup | initiate | — → Buy | — | 54% |
| Mar 31, 2026 | Piper Sandler | initiate | — → Neutral | — | 54% |
| Mar 31, 2026 | Mizuho | initiate | — → Outperform | — | 52% |
| Mar 31, 2026 | Wells Fargo | initiate | — → Overweight | — | 54% |
| Mar 31, 2026 | Morgan Stanley | initiate | — → Overweight | — | 54% |
| Mar 31, 2026 | Evercore ISI Group | initiate | — → Outperform | — | 58% |
| Mar 31, 2026 | B of A Securities | initiate | — → Buy | — | 53% |
| Mar 31, 2026 | BTIG | initiate | — → Buy | — | 52% |
No cross-platform signals in the last 90 days